Basics |
Insmed, Inc.
Insmed Inc is a global biotechnology company. It is focused on developing novel therapies that focus primarily on lung diseases.
|
IPO Date: |
June 1, 2000 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$19.54B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.41 | 2.84%
|
Avg Daily Range (30 D): |
$1.54 | 1.60%
|
Avg Daily Range (90 D): |
$1.41 | 1.80%
|
Institutional Daily Volume |
Avg Daily Volume: |
.79M |
Avg Daily Volume (30 D): |
3.55M |
Avg Daily Volume (90 D): |
2.5M |
Trade Size |
Avg Trade Size (Sh.): |
134 |
Avg Trade Size (Sh.) (30 D): |
68 |
Avg Trade Size (Sh.) (90 D): |
67 |
Institutional Trades |
Total Inst.Trades: |
8,548 |
Avg Inst. Trade: |
$3.42M |
Avg Inst. Trade (30 D): |
$13.3M |
Avg Inst. Trade (90 D): |
$10.85M |
Avg Inst. Trade Volume: |
.09M |
Avg Inst. Trades (Per Day): |
3 |
Market Closing Trades |
Avg Closing Trade: |
$6.49M |
Avg Closing Trade (30 D): |
$77.21M |
Avg Closing Trade (90 D): |
$40.15M |
Avg Closing Volume: |
165.85K |
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-5.93
|
$-1.42
|
$-1.3
|
Diluted EPS
|
$-5.93
|
$-1.42
|
$-1.3
|
Revenue
|
$ 381.03M
|
$ 92.82M
|
$ 104.44M
|
Gross Profit
|
$ 291.47M
|
$ 71.55M
|
$ 78.29M
|
Net Income / Loss
|
$ -1013.26M
|
$ -256.58M
|
$ -235.55M
|
Operating Income / Loss
|
$ -980.89M
|
$ -248.14M
|
$ -230.41M
|
Cost of Revenue
|
$ 89.56M
|
$ 21.28M
|
$ 26.15M
|
Net Cash Flow
|
$ -192.48M
|
$ -151.78M
|
$ 93.58M
|
PE Ratio
|
|
|
|
Splits |
Mar 03, 2011:
1:10
|
Jul 31, 2000:
1:4
|
|
|
|